CareCloud Inc

CareCloud Inc (CCLD) Stock Analysis

$2.160

+0.432 (+20.00%)At close

Loading chart…
High
2.350
Open
2.100
VWAP
2.18
Volume
3.42M
Mkt Cap
32.08M
Low
2.030
Amount
7.45M
EV/EBITDA, TTM
4.89

CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions. The Company provides technology-enabled revenue cycle management and proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its segments include Healthcare IT and Medical Practice Management. The Healthcare IT segment provides software-as-a-service (SaaS) solutions and other services. The Medical Practice Management segment includes the management of three medical practices. Its portfolio of proprietary software and business services includes technology-enabled business solutions. Its cloud-based software helps providers manage practice and patient engagement. Its revenue cycle management services include end-to-end medical billing, eligibility, analytics, and related services.

AI analysis of CareCloud Inc (CCLD)

Hold

CareCloud Inc (CCLD) is currently trading at $1.72, which is near its 52-week low of $1.69. The stock has a forward P/E ratio of 3.471, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.109, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the significant debt increase, with the debt-to-equity ratio soaring to 281.46%, which could impact financial stability.

Valuation Metrics

The current forward P/E ratio for CareCloud Inc (CCLD) is 3.53, compared to its 5-year average forward P/E of -0.61.

Forward P/E

Fair
5Y Average P/E
-0.61
Current P/E
3.53
Overvalued
12.77
Undervalued
-14.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
3.75
Current EV/EBITDA
4.89
Overvalued
6.55
Undervalued
0.95

Forward P/S

Fair
5Y Average P/S
0.52
Current P/S
0.64
Overvalued
0.78
Undervalued
0.25

Alphio AI Price Scenarios for CCLD

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CCLD

$1.95

Scenario price

B

Base

Base · 50%CCLD

$1.84

Scenario price

B

Bear

Bear · 25%CCLD

$1.52

Scenario price

Whales holding CCLD

A

Apollo Global Management, Inc.

+ HoldingCCLD

-2.44%

3M Return

Events Timeline

2026-10-27 (ET)

08:30:00

CareCloud Appoints Mitchell Brie as Chief Compliance Officer

2026-09-29 (ET)

09:00:00

CareCloud Appoints Bonnie Boyer as CFO

2026-06-11 (ET)

14:30:00

Jeff Bezos' New AI Venture Prometheus Raises $12B, Valuation Reaches $41B

2026-05-26 (ET)

08:20:00

CareCloud Acquires Empower Healthcare & Compliance Partners

2026-05-07 (ET)

07:20:00

CareCloud Q1 Revenue $31.27M Exceeds Expectations

News

CCLD FAQ — answered by Alphio AI

CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions. The Company provides technology-enabled revenue cycle management and proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its segments include Healthcare IT and Medical Practice Management. The Healthcare IT segment provides software-as-a-service (SaaS) solutions and other services. The Medical Practice Management segment includes the management of three medical practices. Its portfolio of proprietary software and business services includes technology-enabled business solutions. Its cloud-based software helps providers manage practice and patient engagement. Its revenue cycle management services include end-to-end medical billing, eligibility, analytics, and related services. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

CareCloud Inc (CCLD) is currently trading at $1.72, which is near its 52-week low of $1.69. The stock has a forward P/E ratio of 3.471, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.109, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the significant debt increase, with the debt-to-equity ratio soaring to 281.46%, which could impact financial stability.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading